Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Clinical trial NCT04541589 · COMPLETED
Trial details
- NCT number
- NCT04541589
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2024-08-19
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.